Medication info
Latopu Tablet (Rabeprazole)

Latopu Tablet (Rabeprazole)

Prescription medicationTablet
Ingredient · strength
Lafutidine›10mg / 1 tablet
Manufacturer / importer
IYUN Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
300 tablets/bottle, 30 tablets/bottle
Approval status
Active

MFDS item code 201904378 · Approved 2019.06.26 · Insurance code 658603890

Summary

Main use
Treatment of gastrointestinal disorders (including ulcers, gastritis, and reflux esophagitis); preanesthetic medication; and combination therapy for eradication
Who uses it
Adults
Adult dosage
1. Short-term treatment of gastric ulcers: The usual dose is 10 mg of lafutidine orally twice daily, in the morning and before bedtime. Clinical trial results with treatment for up to 8 weeks showed that most ulcers healed within 8 weeks, although healing time may vary in some patients. 2. Short-term treatment of duodenal ulcers: The usual dose is 10 mg of lafutidine orally twice daily, in the morning and before bedtime. Clinical trial results with treatment for up to 6 weeks showed that most ulcers healed within 6 weeks, although healing time may vary in some patients. 3. Improvement of gastric mucosal lesions in acute and chronic gastritis: The usual dose is 10 mg of lafutidine orally once daily before bedtime. Clinical trial results with treatment for up to 2 weeks showed that most lesions healed within 2 weeks, although healing time may vary in some patients. 4. Concomitant antibiotic therapy in patients with peptic ulcers infected with Helicobacter pylori: Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 or 14 days. 5. Premedication for anesthesia: The usual dose is 10mg of lafutidine per administration, given orally twice (before bedtime on the day before surgery and 2 hours before anesthesia on the day of surgery). 6. Treatment of reflux esophagitis: Administer 10mg of lafutidine orally twice daily.

Ingredients

Manufacturer
IYUN Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastrointestinal disorders (including ulcers, gastritis, and reflux esophagitis); preanesthetic medication; and combination therapy for eradication

  • Gastric ulcer
  • duodenal ulcer
  • gastric mucosal lesions in acute gastritis
  • chronic gastritis
  • peptic ulcer
  • gastroesophageal reflux disease
View approved original text

This medication is used to treat digestive ulcers such as gastric ulcers and duodenal ulcers. It also helps improve the gastric mucosa in patients with acute and chronic gastritis. It is used in combination with antibiotics for patients with peptic ulcers caused by Helicobacter pylori infection. It can also be used as a pre-anesthetic medication and is effective in treating gastroesophageal reflux disease. It aids in relieving symptoms and recovery from various gastric-related diseases.

Dosage and Administration

Adult dosage

1. Short-term treatment of gastric ulcers: The usual dose is 10 mg of lafutidine orally twice daily, in the morning and before bedtime. Clinical trial results with treatment for up to 8 weeks showed that most ulcers healed within 8 weeks, although healing time may vary in some patients. 2. Short-term treatment of duodenal ulcers: The usual dose is 10 mg of lafutidine orally twice daily, in the morning and before bedtime. Clinical trial results with treatment for up to 6 weeks showed that most ulcers healed within 6 weeks, although healing time may vary in some patients. 3. Improvement of gastric mucosal lesions in acute and chronic gastritis: The usual dose is 10 mg of lafutidine orally once daily before bedtime. Clinical trial results with treatment for up to 2 weeks showed that most lesions healed within 2 weeks, although healing time may vary in some patients. 4. Concomitant antibiotic therapy in patients with peptic ulcers infected with Helicobacter pylori: Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 or 14 days. 5. Premedication for anesthesia: The usual dose is 10mg of lafutidine per administration, given orally twice (before bedtime on the day before surgery and 2 hours before anesthesia on the day of surgery). 6. Treatment of reflux esophagitis: Administer 10mg of lafutidine orally twice daily.

Precautions

This medication should not be used in patients who are allergic to its ingredients. Additionally, it contains lactose, so patients with genetic disorders such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should avoid it. Patients who are allergic or sensitive to soybean oil, soy, or peanuts should not use this medication. Patients with a history of hypersensitivity to drugs, patients with liver or kidney function issues, patients on dialysis, elderly patients, and those with abnormalities in lipid metabolism or requiring caution with lipid emulsions should use this medication with caution. This medication can sometimes cause serious allergic reactions such as anaphylaxis or shock; therefore, if symptoms such as facial pallor, low blood pressure, skin rash, or breathing difficulties occur, you should stop taking it immediately and consult a healthcare provider. Liver function impairment or jaundice may occur, so liver function should be monitored periodically, and if there are abnormal signs, use should be discontinued. There may be a decrease in blood cell counts, especially agranulocytosis or thrombocytopenia, and if initial symptoms such as sore throat, general malaise, or fever appear, you should consult a physician immediately. Additionally, rare but serious side effects such as skin rash, seizures, or heart problems have been reported; therefore, you should inform a healthcare provider immediately if any unusual symptoms occur. Pregnant women or those who may become pregnant should take this medication cautiously under the guidance of a physician, and it is advisable for breastfeeding women not to take this medication. Safety in children has not been sufficiently established, so special caution is required when prescribing to children. This medication should be kept out of the reach of children and stored in its original packaging for safety. Elderly patients may have decreased bodily function, so the dosage and frequency should be adjusted, and their condition should be closely monitored. In dialysis patients, drug concentration in the blood may increase, so it should be administered cautiously starting with a low dose. Symptoms of malignant tumors can be masked while using this medication, so if gastric-related symptoms are severe or suspected, additional tests should be performed to confirm the presence of malignant tumors. Patients at risk of fat overload should monitor their blood lipid levels and adjust the dosage as necessary.

Side effects

  • Shock
  • symptoms of anaphylaxis
  • facial pallor
  • hypotension
  • generalized rash
  • shortness of breath
  • hepatic dysfunction
  • jaundice
  • AST (GOT) elevation
  • ALT (GPT) elevation
Show 83 more
  • γ-GTP elevation
  • agranulocytosis
  • pharyngitis
  • general malaise
  • fever
  • thrombocytopenia
  • pancytopenia
  • aplastic anemia
  • seizures
  • interstitial nephritis
  • Stevens-Johnson syndrome
  • Reiter's syndrome
  • rhabdomyolysis
  • atrioventricular block
  • heart failure
  • constipation
  • diarrhea
  • hard stools
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • headache
  • insomnia
  • drowsiness
  • reversible confusional state
  • hallucinations
  • consciousness disturbances
  • dizziness
  • chills
  • heat sensation
  • facial flushing
  • leukocytosis
  • eosinophilia
  • leukopenia
  • erythrocytopenia
  • decreased hematocrit
  • decrease in hematocrit
  • Al-P elevation
  • T-Bil elevation
  • LDH elevation
  • TTT elevation
  • abnormal urine protein
  • BUN elevation
  • increased serum uric acid
  • Cl elevation
  • developmental delay
  • Na elevation
  • K decrease
  • gynecomastia
  • edema
  • malaise
  • glossitis
  • headache
  • urticaria
  • skin rash
  • chest pain
  • subdural hematoma
  • abdominal pain
  • dyspepsia
  • enteritis
  • gastric ulcer
  • erosive gastritis
  • duodenitis
  • distension
  • pharyngotonsillitis
  • upper respiratory tract infection
  • bronchopneumonia
  • tinea
  • cough
  • oropharyngeal pain
  • oropharyngeal discomfort
  • wet cough
  • fatigue
  • chest pain
  • limb pain
  • arthralgia
  • cervical pain
  • pruritus
  • acne
  • contusion
  • insomnia
  • non-alcoholic fatty liver disease

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air or moisture. Additionally, the storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

300 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.